DE69126487T2 - cDNA für Ratten C-Typ natriuretisches Peptid und Vorläuferprotein - Google Patents

cDNA für Ratten C-Typ natriuretisches Peptid und Vorläuferprotein

Info

Publication number
DE69126487T2
DE69126487T2 DE69126487T DE69126487T DE69126487T2 DE 69126487 T2 DE69126487 T2 DE 69126487T2 DE 69126487 T DE69126487 T DE 69126487T DE 69126487 T DE69126487 T DE 69126487T DE 69126487 T2 DE69126487 T2 DE 69126487T2
Authority
DE
Germany
Prior art keywords
rat
cdna
precursor protein
type natriuretic
natriuretic peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69126487T
Other languages
English (en)
Other versions
DE69126487D1 (de
Inventor
Hisayuki Matsuo
Masayasu Kojima
Kenji Kangawa
Naoto Minamino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MATSUO, HISAYUKI, KOBE, HYOGO, JP
Asubio Pharma Co Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of DE69126487D1 publication Critical patent/DE69126487D1/de
Publication of DE69126487T2 publication Critical patent/DE69126487T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69126487T 1990-09-11 1991-09-11 cDNA für Ratten C-Typ natriuretisches Peptid und Vorläuferprotein Expired - Lifetime DE69126487T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP02241074A JP3026352B2 (ja) 1990-09-11 1990-09-11 ラットＣＮＰｃＤＮＡ及び前駆体蛋白

Publications (2)

Publication Number Publication Date
DE69126487D1 DE69126487D1 (de) 1997-07-17
DE69126487T2 true DE69126487T2 (de) 1997-11-27

Family

ID=17068911

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69126487T Expired - Lifetime DE69126487T2 (de) 1990-09-11 1991-09-11 cDNA für Ratten C-Typ natriuretisches Peptid und Vorläuferprotein

Country Status (8)

Country Link
US (1) US5973134A (de)
EP (1) EP0475394B1 (de)
JP (1) JP3026352B2 (de)
AT (1) ATE154387T1 (de)
DE (1) DE69126487T2 (de)
DK (1) DK0475394T3 (de)
ES (1) ES2104639T3 (de)
GR (1) GR3024580T3 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142118A0 (en) * 2001-03-20 2002-03-10 Prochon Biotech Ltd Method and composition for treatment of skeletal dysplasias
EP3446711A1 (de) 2004-03-31 2019-02-27 Kazuwa Nakao Zusammensetzung zur erhöhung der körpergrösse
ES2465141T3 (es) 2004-03-31 2014-06-05 Kazuwa Nakao Remedio o medicamento preventivo para la artritis
PL3404102T3 (pl) 2004-04-21 2021-12-13 Alexion Pharmaceuticals, Inc. Koniugaty do dostarczania do kości i sposób ich wykorzystania do nakierowywania białek na kość
CA2823066A1 (en) 2010-12-27 2012-07-05 Alexion Pharma International Sarl Compositions comprising natriuretic peptides and methods of use thereof
US10052366B2 (en) 2012-05-21 2018-08-21 Alexion Pharmaceuticsl, Inc. Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
US10822596B2 (en) 2014-07-11 2020-11-03 Alexion Pharmaceuticals, Inc. Compositions and methods for treating craniosynostosis
RU2708068C2 (ru) 2014-12-05 2019-12-04 Алексион Фармасьютикалз, Инк. Лечение судорог с использованием рекомбинантной щелочной фосфатазы
JP6868561B2 (ja) 2015-01-28 2021-05-12 アレクシオン ファーマシューティカルズ， インコーポレイテッド アルカリホスファターゼ欠損を有する被験者を治療する方法
CN108350440A (zh) 2015-08-17 2018-07-31 阿雷克森制药公司 碱性磷酸酯的制造
EP3355904A4 (de) 2015-09-28 2019-06-12 Alexion Pharmaceuticals, Inc. Identifizierung wirksamer dosierungsschemata für gewebeunspezifische alkalische phosphatase-enzymersatztherapie von hypophosphatasie
WO2017074466A1 (en) 2015-10-30 2017-05-04 Alexion Pharmaceuticals, Inc. Methods for treating craniosynostosis in a patient
US11065306B2 (en) 2016-03-08 2021-07-20 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in children
US10898549B2 (en) 2016-04-01 2021-01-26 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in adolescents and adults
EP3436052A4 (de) 2016-04-01 2019-10-09 Alexion Pharmaceuticals, Inc. Behandlung von muskelschwäche mit alkalischen phosphatasen
WO2017214130A1 (en) 2016-06-06 2017-12-14 Alexion Pharmaceuticals, Inc. Metal impact on manufacturing of alkaline phosphatases
JP7018933B2 (ja) 2016-08-18 2022-02-14 アレクシオン ファーマシューティカルズ， インコーポレイテッド 気管気管支軟化症の治療方法
US11224637B2 (en) 2017-03-31 2022-01-18 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia (HPP) in adults and adolescents
WO2019190752A1 (en) 2018-03-30 2019-10-03 Alexion Pharmaceuticals, Inc. Manufacturing of glycoproteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3026351B2 (ja) * 1990-07-13 2000-03-27 壽之 松尾 ブタｃｎｐ遺伝子及び前駆体蛋白

Also Published As

Publication number Publication date
GR3024580T3 (en) 1997-12-31
JP3026352B2 (ja) 2000-03-27
EP0475394A3 (en) 1992-09-16
DE69126487D1 (de) 1997-07-17
JPH04121190A (ja) 1992-04-22
EP0475394A2 (de) 1992-03-18
ES2104639T3 (es) 1997-10-16
EP0475394B1 (de) 1997-06-11
DK0475394T3 (da) 1997-07-07
US5973134A (en) 1999-10-26
ATE154387T1 (de) 1997-06-15

Similar Documents

Publication Publication Date Title
DE69126487D1 (de) cDNA für Ratten C-Typ natriuretisches Peptid und Vorläuferprotein
ES2104635T3 (es) Nuevo peptido porcino con una actividad fisiologica (cnp-53).
DK0466175T3 (da) Porcint CNP-gen og præcursor-protein
EP0235205A4 (de) Peptidanalogedes insulinähnlichen wachstumsfaktors-1 bei säugetieren.
ATE68503T1 (de) Atriale peptide.
DE3750197D1 (de) Antagonisten des Fibroblasten-Wachstumsfaktors.
DE69735580D1 (de) An aminosaeure angereicherte speicherproteine, insbesondere an lysin angereicherte mais-gamma-zeine, und diese exprimierende pflanzen
ATE458054T1 (de) Menschliches parathyroidhormon, modifikationen, herstellung und verwendung
DK0859785T3 (da) Cycliske peptidanaloge af somatostatin
DE69027666D1 (de) Herstellung von biologischaktivem insulinähnlichem wachstumsfaktor i aus hochexpressions-wirtszellsystemen
NO971621L (no) Keratinocyttvekstfaktoranaloger
DE3751398D1 (de) Substrat-Peptide.
DE59108261D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
ATE46173T1 (de) Pharmakologisch aktive peptide.
GB2361923A (en) Novel protein
EP0266006A3 (de) Blutdrucksenkende, diuretische Peptide
DK0570244T3 (da) Fremgangsmåde til fremstilling af peptider, der har et C-terminalt prolinamid
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI SUNTORY PHARMA CO., LTD., TOKIO/TOKYO, JP

Owner name: MATSUO, HISAYUKI, KOBE, HYOGO, JP

8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI ASUBIO PHARMA CO., LTD., TOKIO/TOKYO, JP

Owner name: MATSUO, HISAYUKI, KOBE, HYOGO, JP

8327 Change in the person/name/address of the patent owner

Owner name: ASUBIO PHARMA CO., LTD., TOKYO, JP

Owner name: MATSUO, HISAYUKI, KOBE, HYOGO, JP